Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 2007, p. 3776-3777, Vol. 51, No. 10
0066-4804/07/$08.00+0 doi:10.1128/AAC.00837-07
A Novel Insertion Sequence, ISPa26, in oprD of Pseudomonas aeruginosa Is Associated with Carbapenem Resistance

LETTER
Carbapenems are frequently used to treat
Pseudomonas aeruginosa;
however, resistance to the carbapenems is emerging rapidly (
9).
Mutations or deletions in
oprD (
3,
2,
8) commonly result in
lack of OprD expression, blocking the entry of imipenem into
the cell and resulting in resistance to this drug (
6). More
recently, insertional inactivation of
oprD by the insertion
sequence (IS) elements IS
Pa1328 and IS
Pa1635 was described (
7).
Previously, we showed that imipenem resistance in
P. aeruginosa was due to point mutations and deletions in
oprD; IS elements
were not detected in the isolates (
3). To determine whether
IS elements play a role in imipenem resistance in more recent
isolates, we screened for their presence in
oprD in isolates
from two local hospitals.
Fifteen P. aeruginosa isolates were identified as imipenem resistant by disc susceptibility testing (1). Using oprD-specific primers (3), PCR products of the expected size (1,343 bp) were obtained from all but one isolate; strain 8 yielded a product of 2,400 bp. This PCR product was purified and sequenced (3). Analysis of the sequencing data indicated that oprD was disrupted at nucleotide position 35 by the insertion of a 1,193-bp sequence (GenBank accession no. EU000222) containing features of an IS element. The sequence is flanked by 16-bp terminal imperfect inverted repeats and contains an open reading frame (972 bp) with 93.8% identity to TnpA of ISPsy2 from Pseudomonas syringae pv. eriobotryae. No homology with P. aeruginosa PAO1 nor PA14 was detected. This novel IS element, designated ISPa26, resulted in a 4-bp (CTGG) target duplication at the site of insertion in oprD.
To determine whether ISPa26 was present, albeit not in oprD, in the other 14 isolates, PCR assays using primers to specifically amplify tnpA of ISPa26 (ISPa26F, 5'-GATTGCTCTGATCAAACC-3', and ISPa26R, 5'-ATCCAAATGTTCGACAGG-3') were carried out. Amplicons corresponding to ISPa26 tnpA were obtained from four additional imipenem-resistant isolates (strains 1, 6, 7, and 286). Interestingly, the element was also detected in two imipenem-susceptible isolates (strains 12 and 529); ISPa26 was not detected in 7 clinical P. aeruginosa isolates from Canada, France, and Japan. Using pulsed-field gel electrophoresis genotyping (www.hpa.org.uk), five of the seven isolates containing ISPa26 (Table 1) were shown to be clonally related.
To investigate the IS
Pa26 copy number in
P. aeruginosa, genomic
DNA was digested with BamHI, which does not cut within IS
Pa26,
and hybridized (
4) to PCR-amplified IS
Pa26 tnpA (data not shown).
One hybridization signal was observed in each of the two imipenem-susceptible
isolates, as well as from two of the imipenem-resistant isolates
(6 and 7), suggesting that these isolates harbor at least one
copy of IS
Pa26. Two signals were detected in strain 1 and, possibly,
in strain 286, suggesting that these isolates harbor at least
two copies of IS
Pa26. Interestingly, the hybridization study
indicates that strain 8, which contains an insertionally inactivated
oprD, has at least three copies of this element, suggesting
mobility of the element. That IS
Pa26 may be mobile in strain
8 could explain its presence in
oprD in this
P. aeruginosa isolate.
In conclusion, we have identified a novel IS element, ISPa26, in P. aeruginosa isolates from hospitals in Cape Town. In one isolate, insertional inactivation of oprD by ISPa26 was associated with carbapenem resistance.

ACKNOWLEDGMENTS
This work was supported by an award from the Medical Research
Council.

FOOTNOTES

Published ahead of print on 6 August 2007.


REFERENCES
1 - National Committee for Clinical and Laboratory Standards. 2006. Performance standards for MIC testing. Approved standard M100-S13 (M7). NCCLS, Wayne, PA.
2 - Pirnay, J.-P., D. De Vos, D. Mossialos, A. Vanderkelen, P. Cornelis, and M. Zizi. 2002. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ. Microbiol. 4:872-882.[CrossRef][Medline]
3 - Segal, H., J. Paulsen, and B. G. Elisha. 2003. Identification of novel mutations in oprD from imipenem-resistant clinical isolates of Pseudomonas aeruginosa. South. Afr. J. Epidemiol. Infect. 18:85-88.
4 - Segal, H., S. Garny, and B. G. Elisha. 2005. Is ISABA-1 customized for Acinetobacter? FEMS Microbiol. Lett. 243:425-429.[CrossRef][Medline]
5 - Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]
6 - Trias, J., and H. Nikaido. 1990. Outer membrane protein D2 catalyses facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34: 52-57.[Abstract/Free Full Text]
7 - Wolter, D. J., N. D. Hanson, and P. D. Lister. 2004. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol. Lett. 236:137-143.[CrossRef][Medline]
8 - Yoneyama, H., and T. Nakae. 1993. Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:2385-2390.[Abstract/Free Full Text]
9 - Zavascki, A. P., P. B. Gaspareto, A. F. Martins, A. L. Gonçalves, and A. L. Barth. 2005. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-ß-lactamase in a teaching hospital in southern Brazil. J. Antimicrob. Chemother. 56:1148-1151.[Abstract/Free Full Text]
| | | | | |
Joanna C. Evans
Division of Medical Microbiology Institute of Infectious Diseases and Molecular Medicine University of Cape Town Anzio Road Observatory 7925 Cape Town, South Africa
Heidi Segal*
Division of Medical Microbiology National Health Laboratory Service University of Cape Town Anzio Road Observatory 7925 Cape Town, South Africa
|
| | | | | |
* Phone: 27 21 4066793, Fax: 27 21 4066796, E-mail: Heidi.Segal{at}uct.ac.za |
Antimicrobial Agents and Chemotherapy, October 2007, p. 3776-3777, Vol. 51, No. 10
0066-4804/07/$08.00+0 doi:10.1128/AAC.00837-07
This article has been cited by other articles:
-
Lister, P. D., Wolter, D. J., Hanson, N. D.
(2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev.
22: 582-610
[Abstract]
[Full Text]